[Clinical studies on amikacin for infectious diseases following intravenous drip infusion (author's transl)]. 1982

T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai

An antibiotic drug of aminoglycoside group, amikacin (AMK) for parenteral use was used to 8 hospitalized patients: 4 with acute or subacute cholecystitis and cholangitis, 4 with acute peritonitis (3 cases were due to acute appendicitis and a case was torsion of right ovarian cyst). AMK in a dose of 200 mg were administered by intravenous drip infusion for 1 to 2 hours, twice a day for 4 to 9 days. To the cases with biliary tract infection, AMK was treated to preoperatively and to the cases with acute peritonitis, AMK was treated to the postoperatively. Clinical response was excellent in 2 cases, good in 6 cases, fair and poor in none. No adverse effect was observed. The organisms were isolated in 4 cases, 4 were Escherichia coli, 1 was Klebsiella pneumoniae and 1 was Bacteroides fragilis. The MIC for AMK were 3.13-1.56 micrograms/ml in 10(8) and 10(6) cells/ml, except Bacteroides fragilis. Before the operation of above cases, AMK in a dose of 200 mg were administered by intravenous drip infusion in 2 cases (acute and subacute cholecystitis and cholangitis with cholelithiasis), 5 cases by intramuscularly and 1 case by intravenously (acute appendicitis with localized peritonitis). The materials of A-bile, B-bile, wall of gallbladder, the appendix, ascites and serum samples were taken during the operation. AMK concentration was measured by bioassay method with Bacillus subtilis ATCC 6633 as test organism. AMK concentration in B-bile were higher than those in the A-bile. AMK concentrations in wall of gallbladder were much higher than those in A and B-bile. The concentrations after intravenous drip infusion were higher than those after intramuscularly administration. AMK changes of inflammation. In a case of gastric ulcer, AMK 200 mg by intravenous drip infusion was administrated, the AMK concentrations of the tissues at 25 minutes after end of infusion, they were 15.00 micrograms/g in gastric ulcer, 7.20 micrograms/g in normal gastric wall, 9.14 micrograms/g in duodenal wall and 8.12 micrograms/g in the omentum, respectively. Serum concentration of AMK on this case at 58 minutes was 15.7 micrograms/ml. Therefore, it was supposed that AMK could be used safety and effective by intravenous drip infusion.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002761 Cholangitis Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both. Cholangitides
D002764 Cholecystitis Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases. Empyema, Gallbladder,Gallbladder Inflammation,Empyema, Gall Bladder,Gall Bladder Empyema,Gallbladder Empyema,Inflammation, Gallbladder

Related Publications

T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
July 1980, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
July 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
March 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
June 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
September 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
April 1980, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
November 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
February 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
June 1981, The Japanese journal of antibiotics,
T Nakamura, and I Hashimoto, and Y Sawada, and J Mikami, and M Saitoh, and K Hattanda, and E Bekki, and H Nishidai, and M Nakanishi, and Y Kasai
May 1979, The Japanese journal of antibiotics,
Copied contents to your clipboard!